Moat Ross's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Apr 8, 2026
- Accession no.
- 0001857177-26-000004
- Filed
- Apr 8, 2026
- Trade date
- Apr 6-7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $115.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moat RossCIK 0001857177 | Officer (CHIEF OPERATING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Class A Ordinary Share | SSaleDisposed | −2,367 | $48.58 | −$114,988.86 | 12,029 | Direct | |
| Apr 7, 2026 | Class A Ordinary Share | MOption exerciseAcquired | +2,477 | –F2 | – | 14,506 | Direct | |
| Apr 7, 2026 | Class A Ordinary Share | FTax withholdingDisposed | −774 | $48.94 | −$37,879.56 | 13,732 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Class A Ordinary Share | MOption exerciseDisposed | −2,477 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
Referenced by the price of 1 transaction in Table I.